Qsemble Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-39,848
Closed -$3.15M 553
2025
Q2
$3.15M Sell
39,848
-66,113
-62% -$5.26M 0.3% 111
2025
Q1
$9.51M Buy
+105,961
New +$9.89M 1.01% 7
2024
Q4
Sell
-47,854
Closed -$5.43M 476
2024
Q3
$5.43M Buy
47,854
+22,480
+89% +$2.67M 1% 9
2024
Q2
$3.14M Buy
25,374
+9,648
+61% +$1.24M 0.6% 41
2024
Q1
$2.08M Buy
+15,726
New +$1.94M 0.45% 67
2023
Q4
Sell
-50,500
Closed -$5.2M 436
2023
Q3
$5.2M Buy
+50,500
New +$5.44M 0.97% 7

Other funds holding MRK

Qsemble Capital Management's MRK Position: Q3 2025 in Review

Qsemble Capital Management sold out of Merck (MRK) in Q3 2025, closing a stake of 39,848 shares — an estimated $3.15M sold.

Qsemble Capital Management first reported a position in MRK in Q3 2023 and held it in 6 quarters. The position peaked at $9.51M in Q1 2025. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Qsemble Capital Management reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Qsemble Capital Management sold 39,848 Merck shares in Q3 2025, an estimated $3.15M.
  • Qsemble Capital Management first reported a position in Merck in Q3 2023 and held it in 6 quarters.
  • Qsemble Capital Management's Merck position peaked at $9.51M in Q1 2025.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Qsemble Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.